Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3888518 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL305260 | 1.00 | — | — | |
| SCHEMBL10533402 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL4514650 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL7043940 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL305184 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL305058 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL153016 | 1.00 | — | — | |
| SCHEMBL2145601 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL31404556 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617749-B2 | Cannabinoid derivatives and precursors, and asymmetric synthesis for same | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2026-05-05 | — | — | US | disclosed |
| EP-4464685-B1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHINETSU CHEMICAL CO (JP) | 2026-02-04 | — | — | EP | disclosed |
| EP-4464685-A1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-20 | — | — | EP | disclosed |
| US-20240368056-A1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| CN-118878394-A | Method for preparing 17-methylalkane compound | 信越化学工业株式会社 | 2024-11-01 | — | — | CN | disclosed |
| US-20220340514-A1 | CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2022-10-27 | — | — | US | disclosed |
| US-20220220089-A1 | CATALYTIC CANNABINOID PROCESSES AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2022-07-14 | — | — | US | disclosed |
| CN-114269717-A | Catalytic cannabinoid processes and precursors | 凯尔化学科技公司 | 2022-04-01 | — | — | CN | disclosed |
| EP-3959193-A1 | CATALYTIC CANNABINOID PROCESSES AND PRECURSORS | Kare Chemical Technologies Inc. (CA) | 2022-03-02 | — | — | EP | disclosed |
| WO-2021046640-A1 | CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2021-03-18 | — | — | WO | disclosed |
| WO-2020232545-A1 | CATALYTIC CANNABINOID PROCESSES AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340514-A1 | CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME | CNR2, CNR1, CYP2A13 | TSHR 3763/4885THRB 4422/4885DNM1 1009/4885 |
| US-20220220089-A1 | CATALYTIC CANNABINOID PROCESSES AND PRECURSORS | CNR1, CNR2, FAAH | TSHR 3997/4885THRB 4441/4885DNM1 935/4885 |
| US-20240368056-A1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | CYP4Z1, CYP51A1, MSMO1 | TSHR 4372/4885THRB 4192/4885DNM1 2623/4885 |
| US-12617749-B2 | Cannabinoid derivatives and precursors, and asymmetric synthesis for same | CNR1, CNR2, OPRD1 | TSHR 1324/4885THRB 2166/4885DNM1 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.